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ABSTRACT 
6-Methoxy-1,2,3,4-tetrahydro-β-carboline (pinoline) and N-acetyl-5-methoxytryptamine 
(melatonin) are both structurally related to 5-hydroxytryptamine (serotonin). Here we 
describe the design, synthesis and characterization of a series of melatonin rigid 
analogues resulting from the hybridization of both pinoline and melatonin structures. 
The pharmacological evaluation of melatonin – pinoline hybrids comprises serotonergic 
and melatonergic receptors, metabolic enzymes (monoamine oxidases), antioxidant 
potential, the in vitro blood-brain barrier permeability, and neurogenic studies. Pinoline 
at trace concentrations and 2-acetyl-6-methoxy-1,2,3,4-tetrahydro-β-carboline (2) were 
able to stimulate early neurogenesis and neuronal maturation in an in vitro model of 
neural stem cells isolated from the adult rat subventricular zone. Such effects are 
presumably mediated via serotonergic and melatonergic stimulation respectively. 
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Introduction 
Pinoline (6-methoxy-1,2,3,4-tetrahydro-β-carboline, sometimes also designated as 
5-methoxytryptoline) belongs to a vast family of bioactive pyridoindoles, found in 
foods, plants and animals.
1
 Pinoline and melatonin are both structurally related to 
serotonin (5-hydroxytryptamine, 5-HT) and to its methoxyl derivative (5-
methoxytryptamine, 5-MeOT). Regarding 5-MeOT, pinoline is a conformational-
restricted analogue and melatonin, its acetamide (Figure 1). 
 
Figure 1. Schematic representation of the approach used in this work and its parent 
structures. Filled arrows represent the common features of the depicted structures. 
Broken arrows show the hybridization of pinoline and melatonin. 
 
  
Initially, pinoline was proposed as the endogenous ligand of the [
3
H]imipramine 
binding site and the adrenoglomerulotropin factor, responsible for the pineal regulation 
of the adrenal gland.
2-5
 Numerous efforts were done to determine the pinoline levels in 
different tissues, resulting in a wide variety of concentrations that ranged from few ng/g 
up to 1 µg/g in brain, pineal and adrenal gland.
6
 However, criticism may apply in 
certain early determinations since the analytical procedures require a fine design of the 
protocol to avoid artifact formation.
7
 Langer et al. (1985) reported the concentration of 
pinoline in the pineal gland to be as low as 2 ng/g in rats,
8
 whereas more recently 
Barker et al. (2013) could not detect pinoline in samples of the same tissue.
9
 As the 
synthesis of pinoline by pineal gland appears to be inexistent, at most scant, such levels 
question the relevance of the neuroendocrine production of pinoline. Even if there is no 
support for an active role of pineal gland in the biosynthesis of pinoline, there are 
reports in the literature suggesting a plausible spontaneous non-enzymatic generation of 
β-carbolines from their corresponding tryptamine precursor.10-13 In the case of pinoline, 
its precursor 5-MeOT is indeed synthesized in the pineal gland.
14
  
Numerous reports on the pharmacology of pinoline can be found in the scientific 
literature before controversy arouse on its occurrence as an endogenous neurochemical 
of the pineal gland.
3, 6
 The current interest of this molecule is focused on the study of its 
antioxidant properties and as a probe for cytochrome activity.
15-18
 In recent years and 
beyond its scientific interest, pinoline has also attracted attention of new-age religious 
groups that ascribe enlightening properties to this molecule, probably due to its 
structural resemblance to N,N-dimethyltryptamine, nevertheless no reports of its 
administration to humans have ever been published in peer-reviewed publications.
18, 19
 
The β-carboline scaffold that configures the tricyclic structure of pinoline is also present 
in alkaloids found in different plant species like Banisteriopsis caapi (Malpighiaceae), 
  
employed in Amazonian shamanism for the preparation of the hallucinogenic beverage 
Ayahuasca.
20-22
 Some of these alkaloids are reported to be hallucinogenic per se or 
acting as a coadjutants by inhibiting monoaminoxidase A (MAO-A).
19, 22, 23
 
Pinoline shares with melatonin the 5-methoxyindole, although two major 
structural differences exist between them: the nature of the non-aromatic nitrogen and 
the number of free-rotatable bonds. Like serotonin, pinoline is a secondary amine, 
whose basicity suggests a likely protonated ammonium state at physiologic pH with its 
corresponding positive charge, and a plausible neurotransmitter-like pharmacology. 
Melatonin is a primary amide and the endogenous ligand of melatonergic receptors MT1 
and MT2.
24
 Its carbamoyl moiety is able to intervene both as a donor and acceptor in 
hydrogen bonds, but lacks any absolute charge. With regard on their flexibility, 
melatonin and serotonin have an ethylene chain that can adopt several energetically 
equivalent conformations by free-rotation around the sp
3
 carbons. Conversely, the 
additional methylene that configures the tetrahydropyrido ring of pinoline limits the 
conformational freedom of the molecule, being the relative spatial disposition rather 
fixed. Based on these observations and in our interest in melatonin-based potential 
drugs,
25-28
 we wished to develop a series of melatonin-restricted analogues by 
integrating the main structural features of melatonin within the carboline scaffold of 
pinoline, thus hybridizing both structures (Figure 1). The synthesized compounds 1-5 
were pharmacologically characterized and compared to their parent and related 
structures in serotonergic and melatonergic receptors, metabolic enzymes (monoamine 
oxidases), and in two models related to assess their antioxidant potential and blood-
brain barrier permeability. Provided the neurogenic potential of melatonin
29, 30
 and our 
interest in developing new potential brain-repairing agents,
25
 we also explored the 
  
neurogenic potential of the orthodox melatonin – pinoline hybrid 2 and the parent 
compound pinoline, in neural stem cells.  
 
RESULTS 
Pinoline and related 1,2,3,4-tetrahydro-β-carbolines 1-3 were obtained as outlined 
in Scheme 1. Following an acid-catalysed Pictet-Spengler procedure,
31
 the treatment of 
the appropriate tryptamine with paraformaldehyde in the presence of trifluoroacetic acid 
(TFA) afforded pinoline and its 7-methoxy counterpart (1), both as trifluoroacetate salts 
in fair yields. Acetylation of the above free bases with acetic anhydride proceeded 
smoothly, affording acetylated tetrahydro-β-carbolines 2 and 3 in excellent yields.  
 
 
Scheme 1. Synthesis of pinoline and related 1,2,3,4-tetrahydro-(β or γ)-carbolines 1-5. 
Reagents and conditions. (a) paraformaldehyde, TFA, DCM, rt, 72h; (b) acetic 
anhydride, TEA, MeCN, rt, 1h; (c) 4-piperidone, EtOH, conc. HCl, reflux, 3h; (d) 1-
acetyl-4-piperidinone, methylurea:tartartic acid (70:30), 80 ºC, 90 min. 
 
  
1,2,3,4-Tetrahydro-γ-carbolines 4 and 5 were obtained via Fischer indole 
synthesis, starting from (4-methoxyphenyl)hydrazine hydrochloride and the 
corresponding 4-piperidone using two different procedures (Scheme 1). In the case of 4 
a traditional acid-catalysed method was employed: the starting hydrazine hydrochloride 
was refluxed with 4-piperidone in a mixture of ethanol and aq. HCl, obtaining 4 in low 
yield.
32
 In the synthesis of 5 a different acid source was used. Deep eutectic mixtures 
have proven to be cheap and versatile solvents in organic chemistry and biocatalysis 
with similar properties to traditional ionic liquids, with the additional advantage of 
being green media of much less toxicity to environment and humans.
33, 34
 In this case, a 
eutectic mixture of methylurea and tartaric acid (70:30) provided an acidic polar 
medium able to catalyse Fischer indole synthesis,
35
 and thus 5 was obtained from (4-
methoxyphenyl)hydrazine and 1-acetyl-4-piperidinone in very good yield. 
The binding affinities of pinoline and melatonin – pinoline hybrids (1-5) for 
different serotonin receptors and transporter (5-HTR and SERT, respectively) were 
determined in radioligand displacement studies in transfected cells, stably or transiently 
expressing human 5-HTR or SERT. The results are summarized in Table 1.  
  
  
 
Table 1. Binding profiles to human 5-HTR, and SERT determined by radioligand 
displacement. Ki, µM (pKi ± SEM).
a
 
Compd. 5-HT1A 5-HT2A 5-HT2B 5-HT2C 5-HT7 SERT 
pinoline  
4.335  
(5.36 ± 0.07) 
2.210  
(5.66 ± 0.09) 
0.156  
(6.81 ± 0.06) 
1.503  
(5.82 ± 0.06) 
0.607  
(6.22 ± 0.06) 
0.172  
(6.76 ± 0.05) 
1 
5.797  
(5.24 ± 0.08) 
2.919  
(5.53 ± 0.08) 
0.385  
(6.41 ± 0.05) 
1.258  
(5.90 ± 0.07) 
1.906  
(5.72 ± 0.07) 
0.614  
(6.21 ± 0.09) 
4 >10 
0.229  
(6.64 ± 0.07) 
0.194  
(6.71 ± 0.08) 
0.219  
(6.66 ± 0.06) 
0.938  
(6.03 ± 0.06) 
>10 
 
a 
Data are the mean ± SEM of 3 independent experiments. 
 
Only pinoline and compounds 1 and 4, bearing a protonatable amino group, 
showed affinity for 5-HTR, whereas their acetylated counterparts were inactive (data 
not shown). All three protonatable tetrahydrocarbolines showed rather similar binding 
profiles: Ki values in the low- or sub-micromolar range for 5-HT1A, 5-HT2A, 5-HT2B, 5-
HT2C and 5-HT7 receptors. The similarities were even more obvious in the β-carboline 
derivatives, pinoline, and 1, in which the relative position of the methoxy group did not 
appear to be relevant except for 5-HT7R. The relative position of the protonatable 
nitrogen seemed to be more relevant when comparing the γ-carboline 4 and pinoline. 
The nitrogen in γ-position abolished the binding to 5-HT1AR receptors, but increased the 
affinity for 5-HT2AR and 5-HT2CR while maintaining the affinity for 5-HT2BR and 5-
HT7R unchanged. In the case of the SERT the same structure-activity relationship 
(SAR) was found, the affinity of the methoxy-regioisomers pinoline and 1 was nearly 
identical, whereas the γ-carboline 4 lacked a significant affinity for this transporter.  
  
The intrinsic activity of pinoline, 1 and 4 was further determined at 5-HT2 
receptors (Table 2). The β-carboline derivatives (pinoline and 1) showed a very similar 
qualitative pharmacological profile: partial agonism at the 5-HT2AR, antagonism at the 
5-HT2BR (both in the low micromolar range) and full agonism at the 5-HT2CR (sub-
micromolar range). Pinoline was a fairly potent agonist at 5-HT2CR whereas γ-carboline 
4 was unable to activate any of the tested subtypes.  
 
Table 2. Functional characterization of non-acetylated compounds at 5-HT2R 
determined as intracellular calcium mobilization.
a
 
 5-HT2AR  5-HT2BR  5-HT2CR 
Compd. EC50 Emax n  IC50 n  EC50 Emax n 
pinoline 2.14 ± 0.10 75 1.58  1.12 ± 0.05 1.5  0.033 ± 0.001 95 1.9 
1 3.28 ± 0.15 57 1.35  3.63 ± 0.17 1.3  0.120 ± 0.005 100 1.7 
4 –
b
  19.8 ± 0.9 1.4  –b 
 
a
All EC50 or  IC50 values in µM with ± SEM values. Emax is expressed as a percentage of the 
maximum response elicited by 5-HTR. n represents the Hill coefficient. Experiments were run 
in triplicate. 
b γ-Carboline 4 was unable to activate 5-HT2AR nor 5-HT2CR receptors. 
 
The ability of pinoline and melatonin – pinoline hybrids 1-5 to inhibit monoamine 
oxidase A (MAO-A) and B (MAO-B) was assessed. All compounds were inactive at 
MAO-B and only basic tetrahydro-β-carbolines, namely pinoline and derivative 1, 
showed significant inhibition of the MAO-A isoform, being the inhibition elicited by 
pinoline (IC50 = 41.5 ± 6.3 µM) ~25-fold lower than that of 1 (IC50 = 1.3 ± 0.3 µM). 
  
The affinity of pinoline and hybrids 1-5 for melatonin receptors was determined 
by displacement of the radiolabelled ligand [
125
I]iodomelatonin. Out of the six 
compounds tested only 2 showed significant binding activity for the melatonin receptors 
[Ki (MT1) = 0.69 ± 0.03 µM; Ki (MT2) = 0.33 ± 0.01 µM), being the affinity for MT2 
two-fold higher than for MT1. None of its position isomers (5 or 3) showed any 
significant activity. Neither did any of the parent amino compounds, pinoline or its 
isomers (1 and 4).  
Compound 2 was functionally characterized at MT1 and MT2 receptor subtypes in 
the [
35
S]GTPS binding assay. It is a partial agonist at both receptor subtypes [Emax 
(MT1) = 70%; Emax (MT2) = 77%] in the sub-micromolar range [EC50 (MT1) = 0.34 ± 
0.08 µM; EC50 (MT2) = 0.14 ± 0.07 µM], being slightly more potent at the MT2 
receptor. 
According to the brain-blood barrier model PAMPA (parallel artificial membrane 
permeability assay), pinoline and all melatonin – pinoline hybrids (1-5) showed positive 
CNS-permeability (see Supporting Information). In the case of pinoline, these results 
are in agreement with previous reports in which radiolabelled pinoline demonstrated its 
ability to reach the central nervous system.
36, 37
 
Table 3 shows the antioxidant properties of all compounds determined in the 
oxygen radical absorbance capacity assay (ORAC). Trolox, the aromatic part of vitamin 
E, was used as an internal standard and results are expressed as trolox equivalents 
(micromoles of trolox/micromoles of tested compound) on a comparative scale. Some 
commercially available indoles and indoleamines were included for comparison 
purposes to establish a subtractive structure-activity relationship between different 
moieties. Among all tested molecules, pinoline showed the highest antioxidant capacity 
  
equivalent to 3-fold trolox activity, followed by 1 with a value identical to that 
melatonin. γ-Carboline 4 showed the lowest value among the non-acetylated carbolines. 
Unlike pinoline or 1, its antioxidant potential is maintained when acetylated (5). The 
antioxidant potential of amides 2 and 3 diminished in up to one equivalent compared to 
parent compounds. Melatonin, equivalent to nearly 2.5 units of trolox, showed the 
highest ORAC value within the indoles and indoleamines included in the assay, 
followed by 5-methoxytryptamine (0.5 eq. difference) and 5-methoxyindole (1 eq. 
difference). Non-substituted indole showed significant antioxidant activity similar to 
that of trolox, whereas 1-methylindole was totally devoid of it at 10 μM (data not 
shown).  
 
Table 3. Antioxidant Properties of Melatonin – Pinoline Hybrids 1-5 and Reference 
Compounds Determined in the Oxygen Radical Absorbance Capacity assay (ORAC, 
Trolox Equiv).
a
 
Compd. 
ORAC  
(trolox equiv) 
 
Compd. 
ORAC  
(trolox equiv) 
1 2.39 ± 0.26  melatonin 2.43 ± 0.05 
2 2.07 ± 0.19  5-MeOT 1.95 ± 0.04 
3 1.38 ± 0.08  5-methoxyindole 1.60 ± 0.03 
4 1.83 ± 0.08  indole 1.20 ± 0.02 
5 1.67 ± 0.12  pinoline 3.07 ± 0.25 
 
a
Results are the mean ± SEM of 3 independent experiments. 
 
Being 2 the sole compound able to stimulate a significant response in melatonin 
receptors, its neurogenic potential was determined in an in vitro model of neural stem 
  
cells isolated from the adult rat subventricular zone (SVZ),
38
 using melatonin as 
reference. TuJ-1 and MAP-2 expression was quantified and statistically analysed (one-
way ANOVA analysis with drug treatment as the between-subject factor, followed by t-
Student post hoc test). Our results show that both melatonin and 2 were able to promote 
neurogenesis in the model employed, whereas the melatonergic antagonist luzindole did 
not show any differences compared to control (Figure 2). 2-Treated SVZ neurospheres 
(NS) express more TuJ1 (neuron-specific class III beta-tubulin) and MAP-2 
(microtubule-associated protein 2) than those treated with melatonin. Melatonin-
promoted TuJ1 expression occurred mainly in the outer part of the neurospheres, in 
cells spreading out of the formation, whereas the total expression of MAP-2 was diffuse 
within the neurosphere and occurred mostly in the soma of the neurons. TuJ1 
expression pattern of 2-treated SVZ-NS seemed to correspond to that of melatonin, 
more abundant in the outer parts and in cells spreading out of the NS, but the density of 
expression is comparatively higher. The expression of MAP-2 was dense and 
homogeneous both in the inner and the outer parts of the NS treated with 2. Comparing 
the expression pattern of MAP-2 there were clear differences between melatonin and 2. 
The expression of MAP-2 elicited by the latter was not limited to the neuronal soma but 
irradiated throughout the cell bodies in the proximal part of the neuronal fibbers.  
The implication of melatonin receptors in the neurogenic properties of 2 was 
studied in vitro. When SVZ-NS were preincubated in the presence of the non-selective 
melatonin antagonist luzindole, the expression of both TuJ1 and MAP-2 was blocked. 
The blockade was near complete in the case of MAP-2, but some residual expression of 
TuJ1 remained despite the presence of the antagonist (Figure 2). 
  
  
 
 
Figure 2. Immunostaining of neurogenic markers TuJ1 (green) and MAP-2 (red) in 
SVZ-NS in the presence of different compounds (10 µM) and effect of luzindole (10 
µM) on the expression of neurogenic markers promoted by 2. DAPI (blue) was used as 
nuclear marker. Scale bar, 200 µm. Quantification of TuJ
+
 and MAP-2
+ 
cells in 
neurospheres is shown. Values are the mean ± SD from five neurospheres per condition. 
***p ≤ 0.001 versus vehicle-treated (basal) cultures; ###p ≤ 0.001 versus the values 
obtained in compound 2-treated cultures in absence of luzindole. 
  
  
In a second assay, the neurogenic properties of pinoline were also evaluated in 
vitro in the same model. At 10 μM pinoline potently promoted the irradiated expression 
of both TuJ1 and MAP-2 showing a pattern similar to that of 2 (Figure 3). Pinoline was 
also evaluated at 10 nM as a preliminary study of its intrinsic neurogenic potential at 
trace concentrations. The expression of TuJ1 was little affected by the concentration of 
pinoline, whereas the density of MAP-2 clearly diminished at 10 nM being mostly 
located in the neuronal body. 
 
Figure 3. Immunostaining of neurogenic markers TuJ1 (green) and MAP-2 (red) in 
SVZ neurospheres in the presence of pinoline at different concentrations. DAPI (blue) 
was used as nuclear marker in all cases. Scale bar, 200 µm. Quantification of TuJ
+
 and 
MAP-2
+ 
cells in neurospheres is shown. Values are the mean ± SD from five 
neurospheres per condition. 
***p ≤ 0.001.  
  
DISCUSSION 
Unlike pinoline and its isomers bearing an unsubstituted amino group (1 and 4), 
none of the acetylated compounds (2, 3, and 5) showed any activity at 5-HTRs due to 
the absence of a protonatable amine (Table 1). Binding affinities of pinoline and 
compound 1 were previously reported in rat 5-HT1A, 5-HT2A and 5-HT2C receptors 
together with other β-carbolines.39 Significant differences with their reported values 
were found only in the 5-HT2CR. [
3
H]Mesulergine was the radioligand employed in 
both studies, but in our case both pinoline and 1 showed more affinity for the human 
than for the rat 5-HT2CR, being the difference around one order of magnitude.  
Comparing pinoline and 1 we can conclude that the relative position of the 
methoxy group barely affects the affinity or the intrinsic activity of both β-carbolines at 
5-HT2R whereas the relative position of the basic nitrogen does; γ-carboline 4 is devoid 
of serotonergic activity in 5-HT2CR (Table 2). 
Herein we found that pinoline and 1 are both partial agonists at the 5-HT2AR 
within the low micromolar range. Although direct 5-HTR stimulation by pinoline has 
long been speculated,
37, 40-42
 to the best of our knowledge this is the first time that direct 
agonism is reported at the 5-HT2AR for methoxylated-β-carboline structures. Glennon et 
al. studied some selected hallucinogenic β-carbolines, including harmala alkaloids, at 
the 5-HT2AR and found no IP3 (inositol-1,4,5-triphosphate) accumulation.
39
 Agonism or 
partial agonism at 5-HT2AR is needed to elicit psychedelic effects by classical 
hallucinogens; nevertheless not all agonists at this subtype possess such properties. 
Whether pinoline and/or 1 possess hallucinogenic properties at pharmacological 
concentrations remains unknown.
39
 The described ability of pinoline to substitute for 
LSD in trained rats is scant, but this fact is a shared feature with reportedly 
  
hallucinogenic harmala alkaloids, like harmine and harmaline.
43-45
 Unlike other β-
carbolines, such as the harmala alkaloid harmine (LD50 38 mg/kg i.v. in mice), pinoline 
toxicity is rather low (LD50 112 mg/kg i.v. in mice), although its administration to 
humans has never been reported in the scientific literature.
46, 47
 Most harmala alkaloids 
potently inhibit the MAO-A isoform in the low nanomolar range,
22
 whereas pinoline 
barely showed any significant monoamine oxidase inhibitory effect (MAO-A; IC50 = 
41.5 ± 6.3 µM).
48
 The MAO-A inhibition of pinoline could be of relevance at 
pharmacological doses but not if pinoline occurs in trace amounts under physiological 
conditions. The inhibitory effect in MAO-A is more pronounced in 1, the nor-isomer of 
tetrahydroharmine. Both 1 (IC50 = 1.3 ± 0.3 µM) and tetrahydroharmine show a similar 
IC50 in the low micromolar range.
49
 
To what extent these results could be of relevance in putative endogenous-
occurring pinoline remains unknown, in the same way the presence of endogenous 
pinoline is still controversial. Exogenous origin cannot be excluded, since several β-
carbolines have been reported to be present in foodstuff.
50, 51
 Regardless of the origin of 
the pinoline identified on the pineal gland by Langer et al., such low levels could still be 
of certain relevance in the stimulation of 5-HT2CR. At this particular subtype, pinoline 
half maximal effective concentration (EC50 = 33 nM) is low enough to be of relevance 
upon its occurrence at trace concentrations.
8, 52
 Previous studies revealed the presence of 
radiolabelled pinoline in neuronal membranes where 5-HTRs and SERT are located.
36
 
To the best of our knowledge, the careful determinations of pinoline concentration 
carried out by Langer et al. and more recently by Barker et al. in pineal gland have 
never been performed in adrenal gland; previous reports revealed a much higher 
concentration of pinoline in this gland than in the pineal body.
53, 54
 This fact allows us to 
speculate that, even if the concentration observed could be above its real levels due to 
  
the formation of artifacts, the presence of pinoline in the adrenal gland or that of related 
β-carboline structures with similar pharmacologic properties cannot be excluded.13, 55 
The effect of exogenous administration of pinoline in the hypothalamic-pituitary-
adrenal axis has been described previously, generally associated to the stimulation of 5-
HTRs.
46, 56
 Intraperitoneal administration of pinoline to rats provokes effects that 
resembles those of tricyclic antidepressants, together with some anxiogenic-like 
effects.
57
 Some β-carboline compounds related to harmala alkaloids are antagonists or 
inverse agonists at the benzodiazepine (BZD) binding site, producing anxiogenic 
effects. According to previous reports, pinoline lacks any affinity for the BZD binding 
site or the convulsive potential associated to its antagonism.
58, 59
 However, anxiogenic 
effects are also observed after stimulation of 5-HT2CR, which suggests that pinoline 
anxiogenic-like effects could be mediated by this receptor subtype.
60, 61
 Our results in 
the serotonergic system call for a revision of the behavioural effects resulting from 
exogenous administration of pinoline; effects generally attributed to its inhibitory action 
of SERT and MAO-A.
62, 63
 The behavioural effects caused by pinoline are more likely 
to be the result of an additive, if not synergic, intervention at all three systems. 
Regarding to the radical scavenging properties of the studied compounds, the 
comparison of the ORAC values between pinoline and its 7-methoxy isomer 1 reveal 
that the relative position of the methoxy group seems to play a key role in the 
antioxidant properties of tetrahydro-β-carbolines. The observed difference is probably 
due to the differential radical/charge stabilization contribution of the lone pairs of the 
methoxy group in the oxidation process. Comparing pinoline and 5-MeOT, the 
antioxidant potential of the latter is 1 trolox eq. lower. 5-MeOT is essentially an open-
ring pinoline what suggests that the plausible ring opening of the tetrahydropyrido cycle 
in the presence of oxidant species confers to the tricyclic molecule added antioxidant 
  
potential compared to the lineal amine. The inverse structural analogy can be made 
between melatonin and 2, being melatonin antioxidant potential slightly higher. This 
difference could be possibly related to the nature of the nitrogen in both pairs: amine, in 
the case of 5-MeOT/pinoline; and amide, in the case of melatonin/derivative 2. The 
acetylation resulted in a dramatic reduction of the antioxidant potential of tetrahydro-β-
carbolines (pinoline/2, 1/3) but not in the case of tetrahydro-γ-carbolines (4/5). The only 
amine-amide pair in which acetylation results in improved antioxidant potential is in the 
case of 5-MeOT/melatonin.  
Melatonin’s chemical structure is known to intrinsically possess receptor-
independent antioxidant properties.
64, 65
 Cyclic 3-hydroxymelatonin (3-OHM) and other 
acyclic derivatives, such as N1-acetyl-5-methoxy-kynuramine (AMK) and N1-acetyl-N2-
formyl-5-methoxykynuramine (AFMK), are metabolites formed as the result of 
oxidative degradation of melatonin that showed also good radical scavenging 
activities.
66, 67
 Their structures suggest that melatonin’s antioxidant hotspot is located 
between positions C2 and C3 within the 5-methoxyindole (Scheme 2). Even though it 
does not seem obvious looking at the structure of such compounds, our data suggest that 
the acetamido group of melatonin should play a role in the oxidative degradation, i.e. 
stabilizing the tricyclic structure of 3-OHM, or in later phases of the scavenging 
cascade. Removal of the ethyl-acetamido group in melatonin or the tetrahydropyrido 
ring in pinoline leaves the bare 5-methoxyindole, the common heteroaromatic core of 
both compounds. This small scaffold is able to retain a significant antioxidant potential. 
Comparing indole and 5-methoxyindole, nearly one third of the antioxidant effect of the 
latter is attributable to the 5-methoxy group substitution. The contribution of the proton 
in position 1 seems to be even greater, being the 1-methylindole totally devoid of any 
antioxidant activity at testing concentration (10 µM). 
  
 
Scheme 2. Melatonin oxidative degradation (OD) hotspots. Structure of cyclic 3-
hydroxymelatonin (3-OHM) and kynuramines (AMK, AFMK). 
 
Out of this antioxidant SAR no structural conclusions can be drawn to determine 
which decorations are best to enhance the reactivity in the presence of oxidant species. 
The antioxidant nature of pinoline and melatonin cannot be simply attributed to the 
reactivity of the 5-methoxyindole nucleus, nor envisioned as the result of a combination 
of chemical fragments that contribute separately to the whole antioxidant potential; 
instead, it suggests a more complex and optimized interaction between the moieties 
integrated around the heteroaromatic indole scaffold. Additional considerations should 
be made taking into account the nature of the ORAC assay. This experiment is able to 
measure the reactivity of a certain molecule against reactive oxygen species (ROS), but 
it is important to mention that in vivo other radicals are present as well, such as reactive 
nitrogen species for which this model it is not valid. Moreover molecules like 
melatonin, and probably pinoline, can mediate antioxidant responses within the cell via 
membrane receptors, interaction with transcription factors or by other mechanisms not 
directly related to the chemical reactivity of the molecule.
68
 Pinoline has been proposed 
to have a direct role as DNA protecting agent against oxidative damage, and indeed 
some β-carbolines with antitumoral properties have demonstrated their ability to bind to 
it.
58
 As abovementioned, radiolabelled pinoline was found to bind significantly to 
  
mitochondria, where an eventual malfunction in the respiratory chain can result in the 
production of oxidative species.  
Derivatives 2, 3 and 5 are conformationally-restricted melatonin analogues. The 
only compound that showed significant affinity and activity at the melatonin receptors 
is the structurally orthodox melatonin – pinoline hybrid 2. Compared to melatonin’s 
subnanomolar affinity for MT1 and MT2 receptors, affinity of hybrid 2 was penalized by 
three orders of magnitude in both subtypes [Ki (MT1) = 685 ± 25 nM; Ki (MT2) = 330 ± 
10 nM)]. Unlike some previously reported melatonin restricted analogues, in our case 
the rigidity through a secondary amide renders impossible a hydrogen bond.
69, 70
 This 
interaction of the amide group with the receptor appears to be relevant at least for the 
MT1 subtype.
71
 As β-carboline 2 is a partial agonist at both receptors, its ability to 
activate both MT1 and MT2 suggests that the union of 2 to these receptors should occur 
in an analogous way to that of melatonin. None of the other melatonin restricted 
analogues reported in this work showed any activity at melatonergic receptors. 
Compound 2 also demonstrated its ability to stimulate early neurogenesis and 
neuronal maturation in adult rat SVZ-NS to an extent comparable or superior to 
melatonin. The blockade of the expression of neurogenic markers exerted by luzindole, 
together with its demonstrated agonistic properties at the melatonin receptors allow us 
to infer that the neurogenic effect of 2 is mediated by MT1 and MT2 receptors. Both 
melatonin and pinoline, the two compounds embedded within the structural hybrid 2 
demonstrated their in vitro neurogenic properties. In the case of melatonin its 
neurogenic effect can be effectively blocked likewise by luzindole.
30
 Pinoline does not 
interact with MT1 or MT2 receptor, but is able to evoke agonistic response in serotonin 
receptors. The stimulation of serotonin receptors 5-HT1A and 5-HT2 is known to 
increase the neurogenesis rate in adult rat brain.
72, 73
 Therefore, taking into account the 
  
serotonergic pharmacological profile of pinoline we hypothesize that its neurogenic 
effect could be at least partially mediated by serotonin receptors.  
 
Conclusions 
We have synthesized and studied the SAR of a series of pinoline isomers and 
pinoline – melatonin hybrids able to penetrate into the central nervous system. We have 
characterized their pharmacological profile, which was compared to their parent amino 
compounds in different enzymes and receptor systems. This systematic study has 
allowed us to identify 1 and pinoline as full agonists at the 5-HT2CR and partial agonists 
at the 5-HT2AR. To the best of our knowledge, this represents the first report of β-
carbolines resembling harmala alkaloids by exerting direct agonism at the 5-HT2AR. 
Pinoline has been long known to be both a SERT and MAO-A inhibitor; our results 
demonstrate that it indeed binds to the serotonin transporter, and that it weakly inhibits 
MAO-A. Thus, direct action of pinoline on serotonergic receptors could be as relevant 
in its behavioural effects as the earlier known indirect effects via increased serotonin 
concentration, as the result of lowered serotonin metabolism or inhibited reuptake. 
We have further studied the potential of melatonin and pinoline to act as direct 
radical scavengers in the presence of oxidant species. The results obtained reveal that 
both pinoline and melatonin are optimal antioxidant structures that cannot be envisioned 
as the sum of different moieties added over the 5-methoxyindole nucleus.  
We have synthesized and characterized 2 as a structural and pharmacological 
hybrid between melatonin and pinoline that, despite lacking most of the 
pharmacological properties of pinoline, was able to partially retain some activity at 
melatonin receptors MT1 and MT2 and to a lesser extent, their direct scavenging 
  
properties in vitro. Nevertheless the most prominent feature of this melatonin restricted 
analogue is its neurogenic potential in vitro; a response effectively blocked by luzindole 
and superior to that of melatonin. Taking into account its predicted ability to permeate 
through the blood-brain barrier, further studies in vivo would be required to determine if 
its potent neurogenic properties are also observed in the original cell niche. 
Additionally we have demonstrated that pinoline was able to stimulate 
neurogenesis in vitro at low nanomolar concentration; an effect that could be, at least 
partially, mediated by its agonistic properties at serotonergic receptors. Be as it may, 
trace endogenous neurochemical or dietary β-carboline, pinoline neurogenic properties 
underscore its ability to potently interact with biological systems exhibiting an 
interesting pharmacological profile as an investigational tool, even at very low 
concentrations.  
  
METHODS 
Materials. Melatonin–pinoline hybrids (1-5) were obtained using described synthetic 
sequences, in good overall yields. All molecules gave satisfactory analytical (HPLC-
MS) and spectroscopic data (
1
H- and 
13
C-NMR), in good agreement with their 
structures. 
Assays for 5-HT Receptors and 5-HT Transporter. Ki determinations, agonist and 
antagonist functional data were generously provided by the National Institute of Mental 
Health's Psychoactive Drug Screening Program, University of North Carolina at Chapel 
Hill, USA. Radioligands and cell lines employed for determining binding affinities 
were: [
3
H]8-OH-DPAT in CHO (Chinese hamster ovary) cells stably expressing human 
5-HT1AR, [
3
H]ketanserin in HEKT cells transiently expressing human 5-HT2AR, 
[
3
H]LSD in HEKT cells stably expressing human 5-HT2BR, [
3
H]mesulergine in Flp-IN 
HEKT cells stably expressing human 5-HT2CR, [
3
H]LSD in HEKT cells stably 
expressing human 5-HT7R and [
3
H]citalopram in HEKT cells stably expressing human 
SERT. Functional characterization of compounds in 5-HT2A, 5-HT2B and 5-HT2C was 
performed in transfected Flp-In HEK cells stably expressing the corresponding receptor 
subtype in the calcium mobilization FLIPR
TETRA 
assay. Detailed experimental protocols 
are described in the PDSP web site.
74
 
Determination of human MAO Isoforms Activity. The potential effects of 
compounds on human MAO activity were investigated by measuring their effects on the 
production of hydrogen peroxide from p-tyramine, using the Amplex

 Red MAO assay 
kit (Molecular Probes, Inc., Eugene, Oregon, USA) and microsomal MAO isoforms 
prepared from insect cells (BTI-TN-5B1-4) infected with recombinant baculovirus 
containing cDNA inserts for human MAO-A or MAO-B (Sigma-Aldrich). The 
  
production of H2O2 catalysed by MAO isoforms was detected using 10-acetyl-3,7-
dihydroxyphenoxazine (Amplex
 
Red reagent) that reacts with H2O2 in the presence of 
horseradish peroxidase to produce the fluorescent product resorufin. In this study 
hMAO activity was evaluated following the general procedure previously described.
75
 
Assays for MT1 and MT2 Receptor Subtypes. Binding and functional characterization 
of compounds in melatonergic receptors were carried out in transfected CHO cells 
stably expressing the human MT1R or MT2R, using 2-[
125
I]iodomelatonin as radioligand 
and following described protocols.
76
 
In vitro Blood–Brain Barrier Permeation Assay (PAMPA). Prediction of the brain 
penetration was evaluated using a parallel artificial membrane permeation assay 
(PAMPA-BBB) and porcine brain lipid (Avanti Polar Lipids) in a similar manner as 
previously described.
25, 77, 78
 
Oxygen Radical Absorbance Capacity Assay. The ORAC-fluoresceine method was 
followed,
79
 using a Polarstar Galaxy plate reader (BMG Labtechnologies GmbH, 
Offenburg, Germany) with 485-P excitation and 520-P emission filters.  
In Vitro Neurogenesis Studies. Adult (8-12 weeks old) male Wistar rats (n = 6 per 
group), housed in a 12 h light-dark cycle animal facility, were used in this study. All 
procedures with animals were specifically approved by the Ethics Committee for 
Animal Experimentation of the CSIC and carried out in accordance with National 
(normative 1201/2005) and International recommendations (Directive 2010/63 from the 
European Communities Council). Special care was taken to minimize animal suffering. 
NS were derived from the SVZ of adult Wistar rats, which were induced to proliferate 
using established passaging methods to achieve optimal cellular expansion according to 
published protocols.
80, 81
 After treatment, cells were processed for 
  
immunocytochemistry with two types of neurogenesis-associated neuronal markers: 
TuJ1, associated with early stages of neurogenesis, and MAP-2, a marker of neuronal 
maturation. DAPI staining was used as a nuclear marker. Basal values were obtained 
under the same conditions, but in the absence of any product. The images were obtained 
using a Nikon fluorescence microscope 90i that was coupled to a digital camera Qi. The 
microscope configuration was adjusted to produce the optimum signal-to-noise ratio. 
The number of TuJ
+
 and/or MAP-2
+
 cells in the neurosphere was estimated from a total 
of five neurospheres per condition over three independent experiments as previously 
described.
82
  
Statistical Determinations. One-way ANOVA analysis for comparisons between 
different treatments on neurospheres was performed using the SPSS statistical software 
package (version 20.0) for Windows (Chicago, IL) followed by Student’s t post hoc 
test. Differences were considered statistically significant at p < 0.05. 
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ABBREVIATIONS 
AMK, N1-acetyl-5-methoxy-kynuramine; AFMK, N1-acetyl-N2-formyl-5-
methoxykynuramine; BZD, benzodiazepine; DAPI, 4',6-diamidino-2-phenylindole; 5-
HT, 5-hydroxytryptamine or serotonin; 5-HTRs, serotonergic receptors; MAO, 
monoamine oxidase; MAP-2, microtubule-associated protein-2; 5-MeOT, 5-
methoxytryptamine; MTRs, melatonergic receptors; NS, neurospheres; OD, oxidative 
  
degradation; 3-OHM, cyclic 3-hydroxymelatonin; ORAC-FL, oxygen-radical 
absorbance capacity by fluorescence; PAMPA-BBB, parallel artificial membrane 
permeation assay for the blood-brain barrier permeation; ROS, reactive oxygen species; 
SERT, serotonin transporter; SVZ, subventricular zone; TuJ1, anti-β-III-tubulin 
antibody. 
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